Results 151 to 160 of about 16,042 (257)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials. [PDF]

J Infect Dis, 2022
Gast C, Bandyopadhyay AS, Sáez-Llorens X, De Leon T, DeAntonio R, Jimeno J, Aguirre G, McDuffie LM, Coffee E, Mathis DL, Oberste MS, Weldon WC, Konopka-Anstadt JL, Modlin J, Bachtiar NS, Fix A, Konz J, Clemens R, Costa Clemens SA, Rüttimann R.   +19 more
europepmc   +1 more source

Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak - Tajikistan, 2020-2021. [PDF]

MMWR Morb Mortal Wkly Rep, 2022
O'Connor P, Huseynov S, Nielsen CF, Saidzoda F, Saxentoff E, Sadykova U, Kormoss P.   +6 more
europepmc   +1 more source

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.

Lancet Glob Health, 2023
Kennedy SB, Macklin GR, Mason Ross G, Lopez Cavestany R, Moukom RA, Jones KAV, Mainou BA, Massaquoi MBF, Kieh MWS, Mach O.   +9 more
europepmc   +1 more source

Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine. [PDF]

Vaccine X, 2021
Konz JO, Schofield T, Carlyle S, Wahid R, Ansari A, Strating JRPM, Yeh MT, Manukyan H, Smits SL, Tritama E, Rahmah L, Ugiyadi D, Andino R, Laassri M, Chumakov K, Macadam A.   +15 more
europepmc   +1 more source

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence during Roll-Out of Type-2 Novel Oral Polio Vaccine [PDF]

Corey M. Peak, Hil Lyons, Arie Voorman, Elizabeth Gray, Laura Cooper, Isobel M. Blake, Kaija Hawes, Ananda S Bandyopadhyay   +7 more
openalex   +3 more sources

Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 — Worldwide, 2016–2017 [PDF]

, 2017
Ousmane M. Diop, Humayun Asghar, Evgeniy Gavrilin, Nicksy Gumede Moeletsi, Gloria Rey-Benito, Fem Julia Paladin, Sirima Pattamadilok, Yan Zhang, Ajay Goel, Arshad Quddus   +9 more
openalex   +1 more source

Assessment of Oral Poliovirus Vaccine Viability and Titer at Delivery Points in Kinshasa, the Democratic Republic of the Congo: Implications for Cold Chain Management. [PDF]

Vaccines (Basel)
Kashitu-Mujinga G, Makaka-Mutondo A, Matondo-Kuamfumu M, Mambu-Mbika F, Bulabula-Penge J, Kabeya-Mampuela T, Nkawa F, Wanet-Tayele G, Nsunda-Makanzu B, Nsele-Muntatu P, Kabamba L, Nkuba-Ndaye A, Cikomola AMWB, Mukamba-Musenga E, Ahuka-Mundeke S.   +14 more
europepmc   +1 more source

Use of killed poliovirus vaccine in a routine immunization program in West Africa [PDF]

, 1984
Evans, A., Maire, Bernard, Parent, Gérard, Salk, D., Schlumberger, M., Stoeckel, P., Van Steenis, G., Van Wezel, A.   +7 more
core   +1 more source

Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional study. [PDF]

Lancet Reg Health Southeast Asia
Saleem AF, Jeyaseelan V, Kazi Z, Zehra M, Alam MM, Macklin G, Cavestany RL, Muhammad S, Rehman N, Mach O.   +9 more
europepmc   +1 more source

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination [PDF]

Brittany A. Comunale, Robin J. Larson, Yea‐Jen Hsu, Erin Jackson-Ward, Chisom Azodoh, Aditi Singh, Lilly D. Engineer   +6 more
openalex   +1 more source